Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 153

1.

Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali.

Téguété I, Dolo A, Sangare K, Sissoko A, Rochas M, Beseme S, Tounkara K, Yekta S, De Groot AS, Koita OA.

PLoS One. 2017 Feb 23;12(2):e0172661. doi: 10.1371/journal.pone.0172661. eCollection 2017.

2.

Knowledge, attitudes, practices and willingness to vaccinate in preparation for the introduction of HPV vaccines in Bamako, Mali.

De Groot AS, Tounkara K, Rochas M, Beseme S, Yekta S, Diallo FS, Tracy JK, Teguete I, Koita OA.

PLoS One. 2017 Feb 13;12(2):e0171631. doi: 10.1371/journal.pone.0171631. eCollection 2017.

3.

De-immunized and Functional Therapeutic (DeFT) versions of a long lasting recombinant alpha interferon for antiviral therapy.

Mufarrege EF, Giorgetti S, Etcheverrigaray M, Terry F, Martin W, De Groot AS.

Clin Immunol. 2017 Mar;176:31-41. doi: 10.1016/j.clim.2017.01.003. Epub 2017 Jan 10.

PMID:
28089609
4.

Innovation, urgency and acceptance at the 9th Vaccine Renaissance.

De Groot AS, Moise L.

Hum Vaccin Immunother. 2016 Dec;12(12):3186-3188. doi: 10.1080/21645515.2016.1254853. No abstract available.

PMID:
28010520
5.

In Vivo Validation of Predicted and Conserved T Cell Epitopes in a Swine Influenza Model.

Gutiérrez AH, Loving C, Moise L, Terry FE, Brockmeier SL, Hughes HR, Martin WD, De Groot AS.

PLoS One. 2016 Jul 13;11(7):e0159237. doi: 10.1371/journal.pone.0159237. eCollection 2016.

6.

Agility in adversity: Vaccines on Demand.

De Groot AS, Moise L, Olive D, Einck L, Martin W.

Expert Rev Vaccines. 2016 Sep;15(9):1087-91. doi: 10.1080/14760584.2016.1205951. Epub 2016 Jul 18.

PMID:
27389971
7.

Barriers to Health Insurance Pre- and Post-Affordable Care Act Implementation in Providence, RI.

Pigoga J, Kibria F, Pinilla M, Bicki A, Joseph V, De Groot AS.

R I Med J (2013). 2015 Dec 1;98(12):35-9.

PMID:
26623454
8.

T cell epitope redundancy: cross-conservation of the TCR face between pathogens and self and its implications for vaccines and autoimmunity.

Moise L, Beseme S, Tassone R, Liu R, Kibria F, Terry F, Martin W, De Groot AS.

Expert Rev Vaccines. 2016 May;15(5):607-17. doi: 10.1586/14760584.2016.1123098. Epub 2016 Feb 15. Review.

PMID:
26588466
9.

Hit-and-run, hit-and-stay, and commensal bacteria present different peptide content when viewed from the perspective of the T cell.

He L, De Groot AS, Bailey-Kellogg C.

Vaccine. 2015 Nov 27;33(48):6922-9. doi: 10.1016/j.vaccine.2015.08.099. Epub 2015 Oct 1.

PMID:
26428457
10.

Development and validation of an epitope prediction tool for swine (PigMatrix) based on the pocket profile method.

Gutiérrez AH, Martin WD, Bailey-Kellogg C, Terry F, Moise L, De Groot AS.

BMC Bioinformatics. 2015 Sep 15;16:290. doi: 10.1186/s12859-015-0724-8.

11.

8th vaccine renaissance: A creative nexus for vaccine developers.

Johnson H, Moise L, Menge A, Beseme S, De Groot AS.

Hum Vaccin Immunother. 2015;11(9):2294-5. doi: 10.1080/21645515.2015.1069453. Epub 2015 Jul 9. No abstract available.

12.

iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines.

Moise L, Gutierrez A, Kibria F, Martin R, Tassone R, Liu R, Terry F, Martin B, De Groot AS.

Hum Vaccin Immunother. 2015;11(9):2312-21. doi: 10.1080/21645515.2015.1061159.

13.

An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8(+) T cell epitopes.

Eickhoff CS, Van Aartsen D, Terry FE, Meymandi SK, Traina MM, Hernandez S, Martin WD, Moise L, De Groot AS, Hoft DF.

Hum Vaccin Immunother. 2015;11(9):2322-8. doi: 10.1080/21645515.2015.1061160. Epub 2015 Jun 24.

14.

H7N9 T-cell epitopes that mimic human sequences are less immunogenic and may induce Treg-mediated tolerance.

Liu R, Moise L, Tassone R, Gutierrez AH, Terry FE, Sangare K, Ardito MT, Martin WD, De Groot AS.

Hum Vaccin Immunother. 2015;11(9):2241-52. doi: 10.1080/21645515.2015.1052197. Epub 2015 Jun 19.

15.

Preclinical development of HIvax: Human survivin highly immunogenic vaccines.

Hoffmann PR, Panigada M, Soprana E, Terry F, Bandar IS, Napolitano A, Rose AH, Hoffmann FW, Ndhlovu LC, Belcaid M, Moise L, De Groot AS, Carbone M, Gaudino G, Matsui T, Siccardi A, Bertino P.

Hum Vaccin Immunother. 2015;11(7):1585-95. doi: 10.1080/21645515.2015.1050572.

16.

Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma.

Tomimaru Y, Mishra S, Safran H, Charpentier KP, Martin W, De Groot AS, Gregory SH, Wands JR.

Vaccine. 2015 Mar 3;33(10):1256-66. doi: 10.1016/j.vaccine.2015.01.037. Epub 2015 Jan 25.

17.

Partial pathogen protection by tick-bite sensitization and epitope recognition in peptide-immunized HLA DR3 transgenic mice.

Shattuck WM, Dyer MC, Desrosiers J, Fast LD, Terry FE, Martin WD, Moise L, De Groot AS, Mather TN.

Hum Vaccin Immunother. 2014;10(10):3048-59. doi: 10.4161/21645515.2014.985498.

PMID:
25517089
18.

Immune camouflage: relevance to vaccines and human immunology.

De Groot AS, Moise L, Liu R, Gutierrez AH, Tassone R, Bailey-Kellogg C, Martin W.

Hum Vaccin Immunother. 2014;10(12):3570-5. doi: 10.4161/hv.36134.

19.

VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever.

Leblanc P, Moise L, Luza C, Chantaralawan K, Lezeau L, Yuan J, Field M, Richer D, Boyle C, Martin WD, Fishman JB, Berg EA, Baker D, Zeigler B, Mais DE, Taylor W, Coleman R, Warren HS, Gelfand JA, De Groot AS, Brauns T, Poznansky MC.

Hum Vaccin Immunother. 2014;10(10):3022-38. doi: 10.4161/hv.34413. Review.

PMID:
25483693
20.

Tregitope: Immunomodulation powerhouse.

Cousens L, Najafian N, Martin WD, De Groot AS.

Hum Immunol. 2014 Dec;75(12):1139-46. doi: 10.1016/j.humimm.2014.10.012. Epub 2014 Oct 22.

Supplemental Content

Loading ...
Support Center